KL4A6 [L2W]

General Information


DRACP ID  DRACP03894

Peptide Name   KL4A6 [L2W]

Sequence  LWKAAAKAAAKLL

Sequence Length  13

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C65H111N17O14

Absent amino acids  CDEFGHIMNPQRSTVY

Common amino acids  A

Mass  156896

Pl  11.1

Basic residues  3

Acidic residues  0

Hydrophobic residues  10

Net charge  3

Boman Index  1130

Hydrophobicity  73.85

Aliphatic Index  136.15

Half Life 
  Mammalian: 5.5 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  5500

Absorbance 280nm  458.33

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 31442359

Title  Effect of terminal arrangement of tryptophan on biological activity of symmetric ?-helix-forming peptides

Doi Not available

Year  2019

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  14033

DRACP is developed by Dr.Zheng's team.